Chemotherapy

In this video, Laleh Melstrom, MD, MS, discusses research on the use of hepatic arterial infusion pump chemotherapy in patients with advanced intrahepatic cholangiocarcinoma presented at ASCO Gastrointestinal Cancers Symposium.

Patients with locoregionally advanced nasopharyngeal carcinoma may benefit from radiotherapy alone, result from a randomized phase 3 study suggest.

The FDA approved nivolumab in combination with cisplatin and gemcitabine for the first-line treatment of adults with unresectable or metastatic urothelial carcinoma, according to a press release.

SAN FRANCISCO — Results presented at the American Academy of Orthopaedic Surgeons Annual Meeting showed different treatment patterns for metastatic long-bone disease had varying effects on patient survivorship.

The first published results of a phase 3 allogeneic T-cell therapy showed a better than 50% response rate in patients with relapsed or refractory Epstein-Barr virus-positive post-transplant lymphoproliferative disease.

The FDA on Friday approved Rybrevant in combination with chemotherapy as the first first-line treatment of locally advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations, Johnson & Johnson announced.

Gemcitabine and platinum chemotherapy administered after nephroureterectomy SIGNIFICSALTY improved OS among certain patients with upper tract urothelial carcinoma, updated results form a randomized phase 3 study showed.

Medicare recipients with various cancer types had more frequent surgical complications when they also had at least one behavioral health disorder, according to study results published in Journal of the American College of Surgeons.

ATLANTA — New molecularly targeted cancer medications can cause ocular surface and retinal toxicities, according to Joseph P. Shovlin, OD, FAAO, at SECO 2024.

David J. Benjamin, MD, recently met with a patient who recalled the moment a previous physician had diagnosed him with cancer.